{"id":19195,"date":"2021-09-03T16:22:11","date_gmt":"2021-09-03T14:22:11","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=19195"},"modified":"2024-05-29T15:55:09","modified_gmt":"2024-05-29T13:55:09","slug":"sobis-aktieagare-foremal-for-ett-rekommenderat-uppkopserbjudande-fran-advent-och-gic","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/sobis-aktieagare-foremal-for-ett-rekommenderat-uppkopserbjudande-fran-advent-och-gic\/","title":{"rendered":"Sobis aktie\u00e4gare f\u00f6rem\u00e5l f\u00f6r ett rekommenderat uppk\u00f6pserbjudande fr\u00e5n Advent och GIC"},"content":{"rendered":"<p class=\"preamble\">Sobi bitr\u00e4ds av Mannheimer Swartling i anledning av Advents och GICs, genom Agnafit Bidco, rekommenderade uppk\u00f6pserbjudande till aktie\u00e4garna i Sobi.<\/p>\n<p>Sobi \u00e4r ett specialiserat, internationellt biofarmaceutiskt f\u00f6retag som g\u00f6r betydande skillnad f\u00f6r m\u00e4nniskor som lever med s\u00e4llsynta sjukdomar. Sobi tillhandah\u00e5ller innovativa behandlingar inom hematologi, immunologi samt f\u00f6r nischindikationer.<\/p>\n<p>Erbjudandet v\u00e4rderar Sobi till cirka 69,4 miljarder kronor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sobi bitr\u00e4ds av Mannheimer Swartling i anledning av Advents och GICs, genom Agnafit Bidco, rekommenderade uppk\u00f6pserbjudande till aktie\u00e4garna i Sobi. Sobi \u00e4r ett specialiserat, internationellt\u2026<\/p>\n","protected":false},"author":7,"featured_media":17748,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-19195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uppdrag","business-group-arbetsratt-och-pensioner","business-group-eu-och-konkurrensratt","business-group-foretagsoverlatelser","business-group-healthcare-and-life-sciences","business-group-publik-ma-och-aktiemarknad"],"acf":[],"lang":"sv","translations":{"sv":19195,"en":19197},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/19195"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=19195"}],"version-history":[{"count":1,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/19195\/revisions"}],"predecessor-version":[{"id":19196,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/19195\/revisions\/19196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media\/17748"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=19195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=19195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=19195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}